Cargando…
Cholinergic Antagonists and Behavioral Disturbances in Neurodegenerative Diseases
Cholinergic antagonists interfere with synaptic transmission in the central nervous system and are involved in pathological processes in patients with neurocognitive disorders (NCD), such as behavioral and psychological symptoms of dementia (BPSD). In this commentary, we will briefly review the curr...
Autores principales: | Mahmoudi, Rachid, Novella, Jean Luc, Laurent-Badr, Sarah, Boulahrouz, Sarah, Tran, David, Morrone, Isabella, Jaïdi, Yacine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138684/ https://www.ncbi.nlm.nih.gov/pubmed/37108085 http://dx.doi.org/10.3390/ijms24086921 |
Ejemplares similares
-
Incremental Value of CSF Biomarkers in Clinically Diagnosed AD and Non-AD Dementia
por: Oudart, Jean-Baptiste, et al.
Publicado: (2020) -
Factors associated with quality of life in patients with Alzheimer’s disease
por: Barbe, Coralie, et al.
Publicado: (2018) -
Predictive Factors of Rapid Cognitive Decline in Patients with Alzheimer Disease
por: Barbe, Coralie, et al.
Publicado: (2016) -
Proteostasis Disturbances and Inflammation in Neurodegenerative Diseases
por: Sonninen, Tuuli-Maria, et al.
Publicado: (2020) -
Inherited and Acquired Decrease in Complement Receptor 1 (CR1) Density on Red Blood Cells Associated with High Levels of Soluble CR1 in Alzheimer’s Disease
por: Mahmoudi, Rachid, et al.
Publicado: (2018)